While insulin resistance is an established risk factor for many chronic diseases, its drivers remain unclear. Here, extensive ...

In its response, Yuzhong Three Gorges A pointed out that while the company's application of AI technology is not yet extensive, it maintains a high level of attention to this cutting-edge technology.

Discover Beam Therapeutics’ gene editing advances, targeting lifelong cures for serious diseases with precision base editing.